{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:44:13Z","timestamp":1792151053134,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2024-MS-150"],"award-info":[{"award-number":["2024-MS-150"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009965","name":"Dalian Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118542","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:07:48Z","timestamp":1791846468000},"page":"118542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Dauricine induces programmed cell death protein 1 lysosomal degradation in T cells to enhance cytotoxicity against melanoma"],"prefix":"10.1016","volume":"254","author":[{"given":"Minghe","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3535-2426","authenticated-orcid":false,"given":"Jingjian","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-1434","authenticated-orcid":false,"given":"Waleed","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0014-4675","authenticated-orcid":false,"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5932-4857","authenticated-orcid":false,"given":"Shuyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: a systematic analysis for the GBD 2021","volume":"17","author":"Wu","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","article-title":"Global trends in melanoma burden: a comprehensive analysis from the Global Burden of Disease Study, 1990-2021","volume":"92","author":"Sun","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118542_b0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaad.2021.03.109","article-title":"United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019","volume":"85","author":"Aggarwal","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"24","key":"10.1016\/j.bcp.2026.118542_b0020","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, part 1: National cancer statistics","volume":"128","author":"Cronin","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hoc.2020.08.013","article-title":"Immune checkpoint therapies for melanoma","volume":"35","author":"Buchbinder","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.bcp.2026.118542_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2026.118542_b0035","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.bcp.2026.118542_b0040","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2026.118542_b0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/intimm\/dxh194","article-title":"PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells","volume":"17","author":"Iwai","year":"2005","journal-title":"Int. Immunol."},{"issue":"26","key":"10.1016\/j.bcp.2026.118542_b0050","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.118542_b0055","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118542_b0060","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined Nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118542_b0065","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118542_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-981-15-3266-5_3","article-title":"Roles of PD-1\/PD-L1 pathway: signaling, cancer, and beyond","volume":"1248","author":"Ai","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7528","key":"10.1016\/j.bcp.2026.118542_b0075","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010026","article-title":"PD-1 suppresses human CD38(+) circulating Tfr cells and regulates humoral immunity","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"21","key":"10.1016\/j.bcp.2026.118542_b0085","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1002\/cam4.3410","article-title":"Study and analysis of antitumor resistance mechanism of PD1\/PD-L1 immune checkpoint blocker","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118542_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.01.001","article-title":"Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer","volume":"43","author":"Guo","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118542_b0095","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-026-05120-3","article-title":"Natural compounds as immune checkpoint inhibitors in melanoma: a systematic review","author":"Samieefar","year":"2026","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.18632\/aging.102646","article-title":"Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity","volume":"12","author":"Verdura","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.bcp.2026.118542_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.117863","article-title":"A resveratrol derivative RVX-208 inhibits PD-1\/PD-L1 to restrain non-small cell lung cancer as an immunotherapy","volume":"249","author":"Chen","year":"2026","journal-title":"Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.bcp.2026.118542_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010924","article-title":"Molecular mechanism of food-derived polyphenols on PD-L1 dimerization: a molecular dynamics simulation study","volume":"22","author":"Guo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118542_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2024.106043","article-title":"Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model","volume":"166","author":"Wu","year":"2024","journal-title":"Arch. Oral Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118542_b0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI197592","article-title":"Proanthocyanidins enhance antitumor immunity by promoting ubiquitin-proteasomal PD-L1 degradation via stabilization of LKB1 and SYVN1","volume":"136","author":"Xu","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118542_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112098","article-title":"Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer","volume":"133","author":"Luo","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118542_b0130","article-title":"Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bcp.2026.118542_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2025.106401","article-title":"Effect of boswellic acids on the expression of PD-1 and TIGIT immune checkpoints on activated human T cells","volume":"181","author":"Meyiah","year":"2025","journal-title":"Fitoterapia"},{"issue":"10","key":"10.1016\/j.bcp.2026.118542_b0140","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2174\/1568026623666230111154537","article-title":"Impediment of cancer by dietary plant-derived alkaloids through oxidative stress: implications of PI3K\/AKT pathway in apoptosis, autophagy, and ferroptosis","volume":"23","author":"Manogaran","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118542_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104517","article-title":"Analgesic bisbenzylisoquinoline alkaloids from the rhizoma of Menispermum dauricum DC","volume":"107","author":"Wei","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bcp.2026.118542_b0150","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.2147\/DDDT.S471352","article-title":"Dauricine: review of pharmacological activity","volume":"18","author":"Chen","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2026.118542_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093239","article-title":"Kaempferol and its Glycoside, Kaempferol 7-O-Rhamnoside, Inhibit PD-1\/PD-L1 Interaction In Vitro","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.bcp.2026.118542_b0160","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add8910","article-title":"Monitoring alpha-synuclein ubiquitination dynamics reveals key endosomal effectors mediating its trafficking and degradation","volume":"9","author":"Zenko","year":"2023","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.bcp.2026.118542_b0165","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s44319-024-00300-9","article-title":"The USP12\/46 deubiquitinases protect integrins from ESCRT-mediated lysosomal degradation","volume":"25","author":"Yu","year":"2024","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.det.2022.07.007","article-title":"Targeted therapy and immunotherapy in melanoma","volume":"41","author":"Lazaroff","year":"2023","journal-title":"Dermatol. Clin."},{"issue":"19","key":"10.1016\/j.bcp.2026.118542_b0175","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-017-0458-3","article-title":"The use of immunotherapy in the treatment of melanoma","volume":"10","author":"Achkar","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118542_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117141","article-title":"Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020-2024)","volume":"283","author":"Cheng","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118542_b0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/BTT.S166310","article-title":"Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy","volume":"13","author":"Cruz","year":"2019","journal-title":"Biol. Targets Therapy"},{"issue":"11","key":"10.1016\/j.bcp.2026.118542_b0195","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.7150\/thno.130935","article-title":"Small molecules targeting the PD-1\/PD-L1 axis for cancer immunotherapy","volume":"16","author":"Yin","year":"2026","journal-title":"Theranostics"},{"issue":"24","key":"10.1016\/j.bcp.2026.118542_b0200","doi-asserted-by":"crossref","first-page":"16807","DOI":"10.1021\/acs.jmedchem.3c01534","article-title":"Discovery of novel PD-L1 inhibitors that induce the dimerization, internalization, and degradation of PD-L1 based on the fragment coupling strategy","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0205","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jcp.22261","article-title":"Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells","volume":"225","author":"Yang","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118542_b0210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cbf.3826","article-title":"Dauricine exhibits anti-inflammatory property against acute ulcerative colitis via the regulation of NF-kappaB pathway","volume":"41","author":"Zhang","year":"2023","journal-title":"Cell Biochem. Funct."},{"issue":"7","key":"10.1016\/j.bcp.2026.118542_b0215","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1002\/ptr.7089","article-title":"Dauricine inhibits proliferation and promotes death of melanoma cells via inhibition of Src\/STAT3 signaling","volume":"35","author":"Deng","year":"2021","journal-title":"Phytother. Res.: PTR"},{"issue":"11","key":"10.1016\/j.bcp.2026.118542_b0220","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/0115680096282997240101192452","article-title":"Dauricine inhibits non-small cell lung cancer development by regulating PTEN\/AKT\/mTOR and Ras\/MEK1\/2\/ERK1\/2 pathways in a FLT4-dependent manner","volume":"24","author":"Liang","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2026.118542_b0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejca.2017.12.008","article-title":"Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease","volume":"91","author":"Danlos","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2026.118542_b0230","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","article-title":"NF-kappaB: blending metabolism, immunity, and inflammation","volume":"43","author":"Capece","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcp.2026.118542_b0235","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-026-05218-8","article-title":"Dauricine ameliorates intestinal inflammation and oxidative stress in DSS-induced colitis through TLR4\/NLRP3\/GSDMD-mediated pyroptosis and Nrf2 pathway","author":"Wang","year":"2026","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118542_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117560","article-title":"An alkaloid from Menispermum dauricum, dauricine mediates Ca(2+) influx and inhibits NF-kappaB pathway to protect chondrocytes from IL-1beta-induced inflammation and catabolism","volume":"321","author":"Xia","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.118542_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1236892","article-title":"Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-kappaB pathway","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118542_b0250","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.7150\/thno.82920","article-title":"The role of lipid metabolic reprogramming in tumor microenvironment","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118542_b0255","first-page":"39","article-title":"Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer","volume":"10","author":"Luo","year":"2023","journal-title":"Mil. Med. Res."},{"issue":"6892","key":"10.1016\/j.bcp.2026.118542_b0260","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2026.118542_b0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm3979","article-title":"Regulation of RAF protein kinases in ERK signalling","volume":"16","author":"Lavoie","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:45:50Z","timestamp":1792147550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S0006295226008841"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118542","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dauricine induces programmed cell death protein 1 lysosomal degradation in T cells to enhance cytotoxicity against melanoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118542"}}